Lexaria Bioscience Corp. cotiza a 2.80 USD y tiene una capitalización bursátil de $6M. En los últimos 12 meses ha facturado $194000 con un margen de flujo de caja libre del -1483.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter …
| Periodo | 2026-07 | 2026-04 | 2026-01 | 2025-11 |
|---|---|---|---|---|
| Real | $-1.20 | $-0.90 | $-1.05 | $-1.95 |
| Estimado | $-0.90 | $-1.05 | $-1.95 | $-2.35 |
| Sorpresa | -33.3% | +14.3% | +46.2% | +17.0% |
| Métrica | LEXX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 99.6% | 57.0% | +42.6% |
| Operating Margin | -1683.0% | -38.6% | -1644.4% |
| Net Margin | -1686.0% | -33.6% | -1652.4% |
| FCF Margin | -1483.9% | -13.9% | -1470.0% |
| ROE | -398.1% | -40.4% | -357.7% |
| ROA | -285.1% | -32.0% | -253.1% |
| Current Ratio | 2.32 | 2.84 | -0.52 |
| Debt / Equity | — | 0.28 | — |